Business Description
Mega Genomics Ltd
ISIN : KYG5960G1047
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.29 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.78 | |||||
Interest Coverage | 16.2 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.76 | |||||
Beneish M-Score | -3.78 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.1 | |||||
3-Year EBITDA Growth Rate | -24.2 | |||||
3-Year EPS without NRI Growth Rate | -40.7 | |||||
3-Year FCF Growth Rate | 9.3 | |||||
3-Year Book Growth Rate | 50.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.25 | |||||
9-Day RSI | 48.88 | |||||
14-Day RSI | 48.62 | |||||
6-1 Month Momentum % | -21.35 | |||||
12-1 Month Momentum % | -1.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.43 | |||||
Quick Ratio | 5.42 | |||||
Cash Ratio | 3.88 | |||||
Days Inventory | 16.18 | |||||
Days Sales Outstanding | 337.06 | |||||
Days Payable | 239.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | -0.85 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.92 | |||||
Operating Margin % | 18.23 | |||||
Net Margin % | 19.81 | |||||
FCF Margin % | 55.13 | |||||
ROE % | 4.81 | |||||
ROA % | 4 | |||||
ROIC % | 11.26 | |||||
ROC (Joel Greenblatt) % | 27.58 | |||||
ROCE % | 5.6 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 44.83 | |||||
PE Ratio without NRI | 57.54 | |||||
Price-to-Owner-Earnings | 9.18 | |||||
PS Ratio | 9.24 | |||||
PB Ratio | 2.55 | |||||
Price-to-Tangible-Book | 2.55 | |||||
Price-to-Free-Cash-Flow | 16.47 | |||||
Price-to-Operating-Cash-Flow | 12.89 | |||||
EV-to-EBIT | 30.32 | |||||
EV-to-EBITDA | 21.9 | |||||
EV-to-Revenue | 7.3 | |||||
EV-to-FCF | 13.23 | |||||
Price-to-Graham-Number | 2.55 | |||||
Price-to-Net-Current-Asset-Value | 3.12 | |||||
Price-to-Net-Cash | 4.97 | |||||
Earnings Yield (Greenblatt) % | 3.3 | |||||
FCF Yield % | 5.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mega Genomics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 172.84 | ||
EPS (TTM) (HK$) | 0.172 | ||
Beta | 0 | ||
Volatility % | 61.39 | ||
14-Day RSI | 48.62 | ||
14-Day ATR (HK$) | 0.153231 | ||
20-Day SMA (HK$) | 7.718 | ||
12-1 Month Momentum % | -1.28 | ||
52-Week Range (HK$) | 7.35 - 12.4 | ||
Shares Outstanding (Mil) | 228.14 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mega Genomics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mega Genomics Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Mega Genomics Ltd Frequently Asked Questions
What is Mega Genomics Ltd(HKSE:06667)'s stock price today?
When is next earnings date of Mega Genomics Ltd(HKSE:06667)?
Does Mega Genomics Ltd(HKSE:06667) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |